13G Filing: Knoll Capital Management Raises Stake in Synthetic Biologics, Inc. (SYN)

Page 7 of 7

Page 7 of 7 SEC Filing

 

Cusip
No.  
87164U102
13G Page
7 of 7 Pages

 

SIGNATURE

After reasonable inquiry
and to the best of its knowledge and belief, I certify (the undersigned certifies) that the information set forth in this statement
is true, complete and correct.

KNOLL CAPITAL MANAGEMENT, LP

By: /s/ Fred Knoll

Dated: March 1, 2016

Name: Fred Knoll

Title: President

/s/ Fred Knoll

Dated: March 1, 2016 Fred Knoll

 

GAKASA HOLDINGS, LLC.
By: Knoll Capital Management, L.P.,

By: /s/ Fred Knoll

Dated: March 1, 2016

Name: Fred Knoll

Title: President

Page 7 of 7

Follow Theriva Biologics Inc. (NYSEMKT:TOVX)

Page 7 of 7